Paper29911069
Circular RNAs in Cancer - Lessons Learned From microRNAs.
Dragomir M and 1 other. Front Oncol, 2018. Cited by 123 papers, by iCite.
Cite this record
ConductScience Library. Circular RNAs in Cancer - Lessons Learned From microRNAs. Papers, record 29911069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29911069
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA182905 | NCI NIH HHS | United States | R01CA182905 | PubMed and NIH | NIH RePORTER |
| UH3 TR000943 | NCATS NIH HHS | United States | UH3TR000943 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 30280089 | Corrigendum: Circular RNAs in Cancer - Lessons Learned From microRNAs. | https://conductscience.org/library/papers/30280089 |
Source PubMed
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29421663 | Hsa_circ_0001649: A circular RNA and potential novel biomarker for colorectal cancer. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29421663 | PubMed |
| 2 | 21526983 | MicroRNA profiling in cancer. | Clin Sci (Lond) | 2011 | https://conductscience.org/library/papers/21526983 | PubMed |
| 3 | 15258596 | Systematic identification of abundant A-to-I editing sites in the human transcriptome. | Nat Biotechnol | 2004 | https://conductscience.org/library/papers/15258596 | PubMed |
| 4 | 23463100 | Circular RNAs: splicing's enigma variations. | EMBO J | 2013 | https://conductscience.org/library/papers/23463100 | PubMed |
| 5 | 26110611 | cir-ITCH plays an inhibitory role in colorectal cancer by regulating the Wnt/β-catenin pathway. | PLoS One | 2015 | https://conductscience.org/library/papers/26110611 | PubMed |
| 6 | 22158052 | Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. | Cancer Prev Res (Phila) | 2012 | https://conductscience.org/library/papers/22158052 | PubMed |
| 7 | 27298156 | Circular RNA expression in cutaneous squamous cell carcinoma. | J Dermatol Sci | 2016 | https://conductscience.org/library/papers/27298156 | PubMed |
| 8 | 10075718 | A circularized sodium-calcium exchanger exon 2 transcript. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10075718 | PubMed |
| 9 | 28435295 | Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. | Onco Targets Ther | 2017 | https://conductscience.org/library/papers/28435295 | PubMed |
| 10 | 25558066 | Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. | Cell Rep | 2015 | https://conductscience.org/library/papers/25558066 | PubMed |
| 11 | 25242144 | circRNA biogenesis competes with pre-mRNA splicing. | Mol Cell | 2014 | https://conductscience.org/library/papers/25242144 | PubMed |
| 12 | 27886165 | Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. | Cell Death Differ | 2017 | https://conductscience.org/library/papers/27886165 | PubMed |
| 13 | 28657541 | CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630. | Aging (Albany NY) | 2017 | https://conductscience.org/library/papers/28657541 | PubMed |
| 14 | 22319583 | Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. | PLoS One | 2012 | https://conductscience.org/library/papers/22319583 | PubMed |
| 15 | 26600397 | Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. | Cancer Biomark | 2016 | https://conductscience.org/library/papers/26600397 | PubMed |
| 16 | 26683098 | Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme. | Oncotarget | 2016 | https://conductscience.org/library/papers/26683098 | PubMed |
| 17 | 25728652 | Exon Skipping Is Correlated with Exon Circularization. | J Mol Biol | 2015 | https://conductscience.org/library/papers/25728652 | PubMed |
| 18 | 25281217 | Short intronic repeat sequences facilitate circular RNA production. | Genes Dev | 2014 | https://conductscience.org/library/papers/25281217 | PubMed |
| 19 | 28344082 | Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis. | Mol Cell | 2017 | https://conductscience.org/library/papers/28344082 | PubMed |
| 20 | 7684656 | Circular transcripts of the testis-determining gene Sry in adult mouse testis. | Cell | 1993 | https://conductscience.org/library/papers/7684656 | PubMed |
Cited by93
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42450354 | Are RNA Therapies a Solid Foundation or a Frontier Yet to Be Conquered? | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450354 | PubMed |
| 41299506 | Diagnostic and therapeutic potential of exosomal circRNAs in cancer: decoding the circular code toward precision medicine. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41299506 | PubMed |
| 41283951 | Role of non-coding RNAs in radiotherapy sensitivity in non-small cell lung cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41283951 | PubMed |
| 40897893 | Bibliometric-driven research on chemoresistance in breast cancer: knowledge mapping, hotspot evolution, and emerging insights (1994-2024). | Discov Oncol | 2025 | https://conductscience.org/library/papers/40897893 | PubMed |
| 40055485 | Role of epigenetics in paediatric cancer pathogenesis & drug resistance. | Br J Cancer | 2025 | https://conductscience.org/library/papers/40055485 | PubMed |
| 39713143 | The role of circRNA in breast cancer drug resistance. | PeerJ | 2024 | https://conductscience.org/library/papers/39713143 | PubMed |
| 39698574 | Anti-cancer role of curcumin in prostate cancer cells via regulation of m6A-modified circ0030568-FMR1 signaling pathway. | Transl Androl Urol | 2024 | https://conductscience.org/library/papers/39698574 | PubMed |
| 39697533 | Defining the landscape of circRNAs in non-small cell lung cancer and their potential as liquid biopsy biomarkers: a complete review including current methods. | Extracell Vesicles Circ Nucl Acids | 2021 | https://conductscience.org/library/papers/39697533 | PubMed |
| 39659673 | tRNA-derived small RNAs (tsRNAs): establishing their dominance in the regulation of human cancer. | Front Genet | 2024 | https://conductscience.org/library/papers/39659673 | PubMed |
| 39630301 | Expanding on roles of pleckstrin homology-like domain family A member 1 protein. | Cell Tissue Res | 2025 | https://conductscience.org/library/papers/39630301 | PubMed |
| 39091381 | Guidelines for mitochondrial RNA analysis. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/39091381 | PubMed |
| 38892378 | Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892378 | PubMed |
| 38672229 | Plasma Circular RNAs as Biomarkers for Breast Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672229 | PubMed |
| 38628206 | Allicin inhibits the biological activities of cervical cancer cells by suppressing circEIF4G2. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/38628206 | PubMed |
| 38612441 | Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612441 | PubMed |
| 38476331 | Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38476331 | PubMed |
| 38203852 | Specific Circular RNA Signature of Endothelial Cells: Potential Implications in Vascular Pathophysiology. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38203852 | PubMed |
| 38203731 | Non-Coding RNAs as Key Regulators in Lung Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203731 | PubMed |
| 38164139 | Regulatory mechanisms of circular RNAs during human mesenchymal stem cell osteogenic differentiation. | Theranostics | 2024 | https://conductscience.org/library/papers/38164139 | PubMed |
| 38003674 | Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003674 | PubMed |
Genes57
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29911069
GET https://conductscience.org/api/papers/v1/29911069/references?page=2